Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Mukherjee

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2016
A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer and other advanced cancersK N Chi, E Y Yu, C Jacobs, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
An evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunctionC C Barron, M M Alhussein, U Kaur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2025
Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancerT Virtanen, E M Kwan, K Parekh, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2016
A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer and other advanced cancersK N Chi, E Y Yu, C Jacobs, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
An evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunctionC C Barron, M M Alhussein, U Kaur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2025
Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancerT Virtanen, E M Kwan, K Parekh, et al.
Pageof 2